Biopharmaceutical CDMO Service - Global Market insights and Sales Trends 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Biopharmaceutical CDMO Service - Global Market insights and Sales Trends 2024
Global Biopharmaceutical CDMO Service market is projected to reach US$ 29770 million in 2033, increasing from US$ 14640 million in 2022, with the CAGR of 10.3% during the period of 2023 to 2033. Demand from Pharmaceutical Company and Biotechnology Company are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Biopharmaceutical CDMO Service industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Biopharmaceutical CDMO Service key companies include KBI Biopharma, INCOG BioPharma Services, CordenPharma, AGC Biologics, Northway Biotech, PlantForm Corp, Lonza, ADL Biopharma and Catalent, etc. KBI Biopharma, INCOG BioPharma Services, CordenPharma are top 3 players and held % share in total in 2022.
Biopharmaceutical CDMO Service can be divided into Develop Innovative Drugs, Listed Patented Drug, Biosimilars and Others, etc. Develop Innovative Drugs is the mainstream product in the market, accounting for % share globally in 2022.
Biopharmaceutical CDMO Service is widely used in various fields, such as Pharmaceutical Company, Biotechnology Company and Others,, etc. Pharmaceutical Company provides greatest supports to the Biopharmaceutical CDMO Service industry development. In 2022, global % share of Biopharmaceutical CDMO Service went into Pharmaceutical Company filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Biopharmaceutical CDMO Service market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
KBI Biopharma
INCOG BioPharma Services
CordenPharma
AGC Biologics
Northway Biotech
PlantForm Corp
Lonza
ADL Biopharma
Catalent
Future Fields
Vetter Pharma
Stelis
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Cambrex
Pfizer CentreOne
Samsung Biologics
Segment by Type
Develop Innovative Drugs
Listed Patented Drug
Biosimilars
Others
Pharmaceutical Company
Biotechnology Company
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Biopharmaceutical CDMO Service market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Biopharmaceutical CDMO Service introduction, etc. Biopharmaceutical CDMO Service Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Biopharmaceutical CDMO Service market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.![](http://localhost/mraccuracy/images/About Report.webp)
North America, Europe and Asia Pacific are the key regions for Biopharmaceutical CDMO Service industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Biopharmaceutical CDMO Service key companies include KBI Biopharma, INCOG BioPharma Services, CordenPharma, AGC Biologics, Northway Biotech, PlantForm Corp, Lonza, ADL Biopharma and Catalent, etc. KBI Biopharma, INCOG BioPharma Services, CordenPharma are top 3 players and held % share in total in 2022.
Biopharmaceutical CDMO Service can be divided into Develop Innovative Drugs, Listed Patented Drug, Biosimilars and Others, etc. Develop Innovative Drugs is the mainstream product in the market, accounting for % share globally in 2022.
Biopharmaceutical CDMO Service is widely used in various fields, such as Pharmaceutical Company, Biotechnology Company and Others,, etc. Pharmaceutical Company provides greatest supports to the Biopharmaceutical CDMO Service industry development. In 2022, global % share of Biopharmaceutical CDMO Service went into Pharmaceutical Company filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Biopharmaceutical CDMO Service market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
By Company
KBI Biopharma
INCOG BioPharma Services
CordenPharma
AGC Biologics
Northway Biotech
PlantForm Corp
Lonza
ADL Biopharma
Catalent
Future Fields
Vetter Pharma
Stelis
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Cambrex
Pfizer CentreOne
Samsung Biologics
Segment by Type
Develop Innovative Drugs
Listed Patented Drug
Biosimilars
Others
Segment by Application
Pharmaceutical Company
Biotechnology Company
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Biopharmaceutical CDMO Service market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Biopharmaceutical CDMO Service introduction, etc. Biopharmaceutical CDMO Service Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Biopharmaceutical CDMO Service market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
![](http://localhost/mraccuracy/images/About Report.webp)